US 10729768
Combination of anti-CD20 antibody and PI3 kinase selective inhibitor
granted A61KA61K31/519A61K39/3955
Quick answer
US patent 10729768 (Combination of anti-CD20 antibody and PI3 kinase selective inhibitor) held by TG Therapeutics, Inc. expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TG Therapeutics, Inc.
- Grant date
- Tue Aug 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 35
- CPC classes
- A61K, A61K31/519, A61K39/3955, A61K45/06, A61P